We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.3B
AUM Growth
+$326M
Cap. Flow
-$31.7M
Cap. Flow %
-0.31%
Top 10 Hldgs %
48.58%
Holding
592
New
32
Increased
94
Reduced
135
Closed
27

Top Buys

Rank Stock Value
1
WSE
Wise Group
WSE
+$52.3M
2
LLY icon
Eli Lilly
LLY
+$21M
3
NVDA icon
NVIDIA
NVDA
+$17.5M
4
ASML icon
ASML
ASML
+$16.9M
5
AVGO icon
Broadcom
AVGO
+$16.3M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$57.6M
2
ADBE icon
Adobe
ADBE
+$24.5M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$19.1M
5
QCOM icon
Qualcomm
QCOM
+$17.9M

Sector Composition

Rank Sector Weight
1 Technology 32.07%
2 Healthcare 15.31%
3 Consumer Discretionary 12.49%
4 Communication Services 12.1%
5 Financials 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
O icon
451
Realty Income
O
$59.2B
$41.3K ﹤0.01%
666
KAI icon
452
Kadant
KAI
$3.94B
$40.9K ﹤0.01%
130
VTRS icon
453
Viatris
VTRS
$18.5B
$40.3K ﹤0.01%
2,540
GSK icon
454
GSK
GSK
$101B
$39.8K ﹤0.01%
760
CASY icon
455
Casey's General Stores
CASY
$31B
$39.7K ﹤0.01%
50
BCPC
456
Balchem Corp
BCPC
$5.73B
$38.9K ﹤0.01%
230
UGI icon
457
UGI
UGI
$7.53B
$38.1K ﹤0.01%
1,102
KIM icon
458
Kimco Realty
KIM
$16.2B
$37.8K ﹤0.01%
1,492
WMS icon
459
Advanced Drainage Systems
WMS
$10.6B
$36.6K ﹤0.01%
233
JBL icon
460
Jabil
JBL
$38.4B
$36.2K ﹤0.01%
94
CCI icon
461
Crown Castle
CCI
$31.5B
$34.1K ﹤0.01%
450
-9,340
-95% -$820K
HAL icon
462
Halliburton
HAL
$27.7B
$33.7K ﹤0.01%
992
SWKS icon
463
Skyworks Solutions
SWKS
$10.5B
$33.5K ﹤0.01%
494
PEN icon
464
Penumbra
PEN
$12.9B
$33.2K ﹤0.01%
105
-775
-88% -$251K
AAXJ icon
465
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.83B
$33K ﹤0.01%
276
EFOR
466
Everforth Inc
EFOR
$1.34B
$32.6K ﹤0.01%
1,822
MIRM icon
467
Mirum Pharmaceuticals
MIRM
$6.04B
$32.5K ﹤0.01%
278
AMLX icon
468
Amylyx Pharmaceuticals
AMLX
$2.6B
$32.4K ﹤0.01%
1,803
QSR icon
469
Restaurant Brands International
QSR
$26.1B
$31.3K ﹤0.01%
432
STLD icon
470
Steel Dynamics
STLD
$37.7B
$30.7K ﹤0.01%
134
PHYS icon
471
Sprott Physical Gold
PHYS
$16B
$30.4K ﹤0.01%
1,008
PGC icon
472
Peapack-Gladstone Financial
PGC
$820M
$28.4K ﹤0.01%
600
-240
-29% -$10.1K
TRGP icon
473
Targa Resources
TRGP
$57.6B
$28.2K ﹤0.01%
105
PEO
474
Adams Natural Resources Fund
PEO
$776M
$27.4K ﹤0.01%
1,108
SLB icon
475
SLB Ltd
SLB
$78.1B
$26.5K ﹤0.01%
571

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Loring Wolcott & Coolidge Fiduciary Advisors held 592 positions worth $10.3B, up 3.3% from $9.98B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2026 filing shows 32 new, 94 increased, 135 reduced and 27 closed positions. Its largest new stake was Wise Group: 4,378,556 shares worth $52.1M. The largest sale was Booking.com, an estimated $57.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2026 buy was Wise Group: 4,378,556 shares worth $52.1M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Eli Lilly in Q2 2026, an estimated $21M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2026 reduction was Booking.com, cutting an estimated $57.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited RenaissanceRe in Q2 2026, selling an estimated $1.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 49% of its $10.3B portfolio in Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 32 new positions and closed 27 in Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 3.3% quarter-over-quarter to $10.3B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.